Skip to content
TrialScanner

NCT05568706

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Phase 2CompletedENTALead

Registry record

Lead sponsor
Enanta Pharmaceuticals, Inc
Conditions
RSV Infection
Primary completion
Jun 23, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05568706 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.